| Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19 JA Juno, HX Tan, WS Lee, A Reynaldi, HG Kelly, K Wragg, R Esterbauer, ... Nature medicine 26 (9), 1428-1434, 2020 | 450 | 2020 |
| Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19 AK Wheatley, JA Juno, JJ Wang, KJ Selva, A Reynaldi, HX Tan, WS Lee, ... Nature communications 12 (1), 1162, 2021 | 359 | 2021 |
| Suboptimal SARS-CoV-2− specific CD8+ T cell response associated with the prominent HLA-A* 02: 01 phenotype JR Habel, THO Nguyen, CE van de Sandt, JA Juno, P Chaurasia, ... Proceedings of the National Academy of Sciences 117 (39), 24384-24391, 2020 | 191 | 2020 |
| Systems serology detects functionally distinct coronavirus antibody features in children and elderly KJ Selva, CE Van De Sandt, MM Lemke, CY Lee, SK Shoffner, BY Chua, ... Nature communications 12 (1), 2037, 2021 | 138 | 2021 |
| The cell surface mucin MUC1 limits the severity of influenza A virus infection JL McAuley, L Corcilius, HX Tan, RJ Payne, MA McGuckin, LE Brown Mucosal immunology 10 (6), 1581-1593, 2017 | 133 | 2017 |
| CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity THO Nguyen, LC Rowntree, J Petersen, BY Chua, L Hensen, L Kedzierski, ... Immunity 54 (5), 1066-1082. e5, 2021 | 117 | 2021 |
| Immune imprinting and SARS-CoV-2 vaccine design AK Wheatley, A Fox, HX Tan, JA Juno, MP Davenport, K Subbarao, ... Trends in immunology 42 (11), 956-959, 2021 | 86 | 2021 |
| Subdominance and poor intrinsic immunogenicity limit humoral immunity targeting influenza HA stem HX Tan, S Jegaskanda, JA Juno, R Esterbauer, J Wong, HG Kelly, Y Liu, ... The Journal of clinical investigation 129 (2), 850-862, 2019 | 83 | 2019 |
| Self-assembling influenza nanoparticle vaccines drive extended germinal center activity and memory B cell maturation HG Kelly, HX Tan, JA Juno, R Esterbauer, Y Ju, W Jiang, VC Wimmer, ... Jci Insight 5 (10), 2020 | 76 | 2020 |
| Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaques HX Tan, JA Juno, WS Lee, I Barber-Axthelm, HG Kelly, KM Wragg, ... Nature communications 12 (1), 1403, 2021 | 74 | 2021 |
| Cross-lineage protection by human antibodies binding the influenza B hemagglutinin Y Liu, HX Tan, M Koutsakos, S Jegaskanda, R Esterbauer, D Tilmanis, ... Nature communications 10 (1), 324, 2019 | 71 | 2019 |
| Decay of Fc-dependent antibody functions after mild to moderate COVID-19 WS Lee, KJ Selva, SK Davis, BD Wines, A Reynaldi, R Esterbauer, ... Cell Reports Medicine 2 (6), 2021 | 70 | 2021 |
| Inducible bronchus-associated lymphoid tissues (iBALT) serve as sites of B cell selection and maturation following influenza infection in mice HX Tan, R Esterbauer, HA Vanderven, JA Juno, SJ Kent, AK Wheatley Frontiers in immunology 10, 611, 2019 | 60 | 2019 |
| SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses M Koutsakos, A Reynaldi, WS Lee, J Nguyen, T Amarasena, G Taiaroa, ... Immunity 56 (4), 879-892. e4, 2023 | 58 | 2023 |
| Establishment and recall of SARS-CoV-2 spike epitope-specific CD4+ T cell memory KM Wragg, WS Lee, M Koutsakos, HX Tan, T Amarasena, A Reynaldi, ... Nature Immunology 23 (5), 768-780, 2022 | 55 | 2022 |
| Induction of vaginal-resident HIV-specific CD8 T cells with mucosal prime–boost immunization HX Tan, AK Wheatley, R Esterbauer, S Jegaskanda, JJ Glass, ... Mucosal immunology 11 (3), 994-1007, 2018 | 53 | 2018 |
| Standard trivalent influenza virus protein vaccination does not prime antibody-dependent cellular cytotoxicity in macaques S Jegaskanda, TH Amarasena, KL Laurie, HX Tan, J Butler, MS Parsons, ... Journal of virology 87 (24), 13706-13718, 2013 | 50 | 2013 |
| Lung-resident memory B cells established after pulmonary influenza infection display distinct transcriptional and phenotypic profiles HX Tan, JA Juno, R Esterbauer, HG Kelly, KM Wragg, P Konstandopoulos, ... Science immunology 7 (67), eabf5314, 2022 | 47 | 2022 |
| Influenza virus infection enhances antibody-mediated NK cell functions via type I interferon-dependent pathways S Jegaskanda, HA Vanderven, HX Tan, S Alcantara, KM Wragg, ... Journal of virology 93 (5), 10.1128/jvi. 02090-18, 2019 | 44 | 2019 |
| The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants M Koutsakos, WS Lee, A Reynaldi, HX Tan, G Gare, P Kinsella, KC Liew, ... Immunity 55 (7), 1316-1326. e4, 2022 | 43 | 2022 |
